Alzheimer's disease, a progressive neurodegenerative condition, is distinguished by the misfolding and aggregation of proteins within the brain. Beta-amyloid plaques and tau tangles are the main offenders, disrupting neuronal communication and triggering symptoms such as memory loss, cognitive decline, and behavioral changes. This accumulation of abnormal proteins progressively impairs brain function, marking Alzheimer's as the most prevalent form of dementia globally. The disease presents formidable challenges for healthcare systems and families alike. Ongoing research is focused on unraveling the mechanisms behind protein misfolding, identifying early biomarkers, and developing novel therapies to either slow down or stop its advancement. Effective treatments remain elusive, underscoring the intricate nature of protein misfolding diseases and emphasizing the critical need for innovative approaches in diagnosis and treatment.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States